Bifunctional chelators for copper radiopharmaceuticals: the synthesis of [Cu(ATSM)–amino acid] and [Cu(ATSM)–octreotide] conjugates
Authors:
- 1 January 2007
- journal article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- No. 2,p. 209-217
Abstract
Two new bifunctional chelators that are derivatives of the bis(thiosemicarbazone) ATSMH2 proligand have been prepared, one with two phenyl carboxylate substituents on the exocyclic nitrogens (L1H2) and one with a single phenyl carboxylate (L2H2). The new ligands have been characterised by NMR spectroscopy, mass spectrometry and in the case of L1H2 by X-ray crystallography. The copper, nickel and zinc complexes of the new ligands have been synthesised and characterised. Electrochemical measurements show that the copper(II) complexes undergo a reversible reduction attributable to a Cu(II)/Cu(I) process. The new proligands have been tethered to the N-α-Boc-protected amino acids lysine and ornithine using solution and solid phase methods. The new amino acid conjugates form copper complexes and the complexes have been characterised by mass spectrometry and electronic spectroscopy. The bifunctional chelator L2H2 has been conjugated to the tumour targeting peptide octreotide and the new ATSMH2–octreotide conjugate and its copper complex have been characterized by mass spectrometry. These new systems have the potential to be used for new targeted copper radiopharmaceuticals for imaging and therapy.Keywords
This publication has 24 references indexed in Scilit:
- Preparation and Biological Evaluation of Copper-64–Labeled Tyr3-Octreotate Using a Cross-Bridged Macrocyclic ChelatorClinical Cancer Research, 2004
- Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic ComplexesJournal of Medicinal Chemistry, 2004
- Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationshipsJBIC Journal of Biological Inorganic Chemistry, 2002
- Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent Cu-diacetyl-bis(N 4-methylthiosemicarbazone) (Cu-ATSM) in tumor cellsAnnals of Nuclear Medicine, 2001
- Copper-64-diacetyl-bis( N 4 -methylthiosemicarbazone): An agent for radiotherapyProceedings of the National Academy of Sciences, 2001
- Radiometal-Labeled Agents (Non-Technetium) for Diagnostic ImagingChemical Reviews, 1999
- Metal complexes as diagnostic toolsCoordination Chemistry Reviews, 1999
- Comparative studies of Cu-64-ATSM and C-11-Acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in ratsNuclear Medicine and Biology, 1999
- Redox-active metal complexes for imaging hypoxic tissues: structure–activity relationships in copper(ii) bis(thiosemicarbazone) complexesChemical Communications, 1998
- Copper radionuclides and radiopharmaceuticals in nuclear medicineNuclear Medicine and Biology, 1996